About exelixis capital:
Pioneering the Future

At exelixis capital, we are committed to pioneering investments in longevity, circular economy, and exponential technologies to shape a sustainable future.

Founded by a visionary trio, exelixis capital AG stands at the nexus of innovation and responsible investment, championing ventures that promise a circular future, enhanced longevity, and groundbreaking technological advancements. Our mission is to empower exceptional teams dedicated to driving change, by leveraging the collective expertise and resources of our unique and close-knit group of investors.

Investing in Tomorrow:
Our Core Pillars

We believe in the transformative power of integrating longevity, circular economy, and exponential technologies into our investment strategy. This philosophy guides our pursuit of opportunities that not only promise sustainable returns but also contribute positively to societal and environmental progress.


It’s about creating a legacy that transcends generations, fostering a world where innovation fuels a healthier, more sustainable, and technologically advanced society.

Our Team

Meet the dedicated individuals behind exelixis capital AG, a team united by the vision of investing in a future where progress and sustainability intersect.

Dr. Guenther Dobrauz-Saldapenna

Partner

View more
View more

Sebastian von Doering

Partner

View more
View more

Michael Dieckell

Partner

View more
View more

Shirin Karimi Hund

CTO Longevity

View more
View more

Dr. Guenther
Dobrauz-Saldapenna

Partner
gd@exelixis.ch
Dr. Guenther Dobrauz-Saldapenna holds a master’s degree and a doctorate in law from Johannes Kepler University (Austria), an MBA from the University of Strathclyde (Scotland) and has completed advanced training programs at Harvard Business School, Harvard Law School, IMD and Singularity University.
He is co-founder and partner of the Swiss investment firm exelixis capital AG and manages the single family office Dobrauz-Saldapenna 1858 AG in Zurich. Prior to this, Dr. Dobrauz worked for many years as a partner at PricewaterhouseCoopers (PwC), where he was head of the legal department for the whole of Switzerland and significantly expanded it. He was also a member of the Global Legal Leadership Team.
In the first part of his career, he gained valuable experience at Deloitte, an international hedge fund and one of the first Swiss venture capital firms. Over the years, he has published 12 books on innovation, the circular economy and law, over 100 specialist articles and spoken at hundreds of conferences worldwide.

Sebastian von Doering

Partner
svd@exelixis.ch
Sebastian studied architecture at the ETH in Zurich, completed a real estate economist degree at the University of Zurich and undertook further educations in the real estate industry.
He sits on the management board of real estate development companies both in Germany and Switzerland.
He is a creative, open-minded art lover, always looking for new ways of supporting and promoting business.

Michael Dieckell

Partner
md@exelixis.ch
Michael graduated from University of California Riverside with a Bachelor of Science in Business Administration.
He was Managing Director of his family’s office, where he was responsible for VC investments, real estate management as well as a diverse portfolio of other holdings and was on the board of directors of several publicly listed companies.
In 2007 he moved to Zurich, Switzerland where he incorporated his own investment and advisory company.
With an entrepreneurial spirit, he is highly interested in exponential technologies, decentralized business strategies and circular economy.

Shirin Karimi Hund

CTO Longevity
Dr. Shirin Hund is a Harvard trained internal medicine physician and advisory board member to several companies in the fields of preventative medicine and anti-aging diagnostic technologies and treatments.
She received her Bachelor degree with Honors from American University in Washington, D.C. and her medical degree from the University of Connecticut School of Medicine before completing her residency at Harvard Medical School’s teaching hospital, Cambridge Health Alliance. She is board certified in internal medicine by the American Board of Internal Medicine in addition to holding Swiss medical registration. She was part of the founding medical team at the Chenot Group’s flagship center, Chenot Palace Weggis, where she was trained in longevity principles and protocols.
She has received grants to support her interests in improving medical access and services for vulnerable patient populations and was accepted to the Harvard Macy Institute Program for Future Academic Clinician-Educators for her development of an innovative medical education curriculum. She has multiple publications in the fields of medical education, medical humanities, and clinical immunology in the Journal of General Internal Medicine, Academic Medicine, and Immunology. Her mission as a physician is driven by a commitment to healing through medicine, education, and advocacy.